SCHEDULE 13G/A: BlackRock Boosts Stake in QuidelOrtho to 14.8%

BlackRock, Inc. has increased its beneficial ownership in QuidelOrtho Corp's common stock to 14.8%, holding 9,995,336 shares as of June 30, 2025.

Summary

• BlackRock, Inc. filed an Amendment No. 5 to Schedule 13G for QuidelOrtho Corp, disclosing its updated ownership stake.
• As of June 30, 2025, BlackRock beneficially owns 9,995,336 shares of QuidelOrtho Corp's Common Stock.
• This ownership represents 14.8% of the total outstanding common stock of QuidelOrtho Corp.
• BlackRock holds sole voting power over 9,853,000 shares and sole dispositive power over 9,995,336 shares.
• No shared voting or dispositive power is reported by BlackRock.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.
• iShares Core S&P Small-Cap ETF, an entity associated with BlackRock, is noted to have an interest exceeding five percent of QuidelOrtho Corp's total outstanding common stock.

Sentiment

Score: 7

Explanation: The filing indicates a significant and increased passive stake by a major institutional investor, BlackRock, which generally signals confidence in the company. While it's a routine disclosure, the size of the stake and the reputation of the investor are positive indicators. No negative information is presented.

Positives

• Increased institutional ownership by a major asset manager like BlackRock can signal confidence in the company's long-term prospects and stability.
• The passive nature of the investment, as indicated by the Schedule 13G filing, suggests BlackRock is not seeking to influence management or control the company, which can be viewed favorably by existing management and shareholders.

Risks

• The filing itself does not detail specific risks related to QuidelOrtho Corp's business operations or financial health. It primarily serves as a disclosure of passive ownership, indicating that BlackRock is not acquiring the shares for the purpose of changing or influencing control of the issuer.

Future Outlook

NA

Industry Context

This filing reflects a routine regulatory disclosure by BlackRock, one of the world's largest asset managers, regarding its passive investment in QuidelOrtho Corp. It indicates continued institutional interest in the healthcare diagnostics sector, but does not provide broader industry trends or competitive analysis.

Stakeholder Impact

• Shareholders: The increased institutional ownership by BlackRock may be viewed positively, potentially enhancing investor confidence and market liquidity.
• Management: The passive nature of BlackRock's stake, as indicated by the Schedule 13G filing, suggests no immediate intent to influence or challenge current management, which can provide stability.

Key Dates

Recommendation

Keywords

BlackRock, QuidelOrtho Corp, Schedule 13G, Institutional Ownership, Common Stock, Investment, Passive Stake, Asset Management